John Devane serves as a medical and scientific advisor to Sebela Pharmaceuticals. Prior to Sebela Pharmaceuticals, from 2003 to 2012, Dr. Devane founded and served as the Chief Executive Officer of AGI Therapeutics. From 2001 to 2005, Dr. Devane was the founder and CEO of Athpharma Limited. From 1981 to 2001, Dr. Devane worked at Elan Corporation, where he served in several roles including Executive Vice President R&D (Drug Delivery), Vice President R&D, Vice President Regulatory & Clinical Affairs (USA) and Director, Product Development. Dr. Devane holds a BSc and a PhD in pharmacology from the University College Dublin.
Medicine